Open access · CC-BY
via OpenAlex
The Potential Use of Resveratrol for Cancer Prevention
Dominique Vervandier‐Fasseur, Norbert Latruffe
Molecules · 2019 · ▲ 144 citations
Abstract
In addition to the traditional treatments of cancer and cancer prevention, the use of natural compounds, especially those found in food, should be considered. To clarify if resveratrol has the potential for cancer prevention and the possibility of use in therapy, the following must be taken into account: data from epidemiology, clinical protocol (case and control), preclinical studies (lab animals), use of established cell lines as models of cancer cells, test tube assays (enzymes activities), and requirements of nanotechnologies in order to discover new drugs to fight cancer. From this perspective and future expected advances, more information is needed such as improved efficacy, methods of application, and the synergistic sensitization of resveratrol as an adjuvant. In addition, resveratrol nanoformulation is considered to overcome its weak bioavailability.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/molecules24244506
- Canonical
- link ↗
- Fetched
- 2026-08-31 MST
Cite this
APA
Vervandier‐Fasseur, D., & Latruffe, N. (2019). The Potential Use of Resveratrol for Cancer Prevention. <em>Molecules</em>. https://doi.org/10.3390/molecules24244506
Vancouver
Vervandier‐Fasseur D, Latruffe N. The Potential Use of Resveratrol for Cancer Prevention. Molecules. 2019. doi:10.3390/molecules24244506.
BibTeX
@article{dominique2019ThePot,
title = {The Potential Use of Resveratrol for Cancer Prevention},
author = {Dominique Vervandier‐Fasseur and Norbert Latruffe},
journal = {Molecules},
year = {2019},
doi = {10.3390/molecules24244506},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Cell and Developmental Biology 2025
Open access · CC-BY
Current advances and future prospects of cell reprogramming in progeroid syndromes
Cell 1999
Open access · OA
For Better or Worse? Telomerase Inhibition and Cancer
Stem Cells 2009
Open access · OA
Mesenchymal Stromal Cells: Current Understanding and Clinical Status
Cancers 2021
Open access · CC-BY
Senolytics for Cancer Therapy: Is All that Glitters Really Gold?
BMC Evolutionary Biology 2007
Open access · CC-BY
Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer
Nature 2017
Citation only